← FDA Drug Approvals (Drugs@FDA)

SYMJEPI

NDA · New Drug Application · Sponsor: ADAMIS PHARMS CORP · Approved 2017-06-15

Drug application

FDA Application #

NDA207534

Application type

New Drug Application

Brand name

SYMJEPI

Generic name

Epinephrine

Active ingredients

EPINEPHRINE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

ADAMIS PHARMS CORP

First approval

2017-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown